Correlation Between CTBC Financial and Excelsior Biopharma

Can any of the company-specific risk be diversified away by investing in both CTBC Financial and Excelsior Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTBC Financial and Excelsior Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CTBC Financial Holding and Excelsior Biopharma, you can compare the effects of market volatilities on CTBC Financial and Excelsior Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTBC Financial with a short position of Excelsior Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTBC Financial and Excelsior Biopharma.

Diversification Opportunities for CTBC Financial and Excelsior Biopharma

0.65

Correlation Coefficient

CTBC Financial  Excelsior Biopharma

Poor diversification

The 3 months correlation between CTBC and Excelsior is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding CTBC Financial Holding and Excelsior Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Excelsior Biopharma and CTBC Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTBC Financial Holding are associated (or correlated) with Excelsior Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Excelsior Biopharma has no effect on the direction of CTBC Financial i.e., CTBC Financial and Excelsior Biopharma go up and down completely randomly.

Pair Corralation between CTBC Financial and Excelsior Biopharma

Assuming the 90 days trading horizon CTBC Financial is expected to generate 5.92 times less return on investment than Excelsior Biopharma. But when comparing it to its historical volatility, CTBC Financial Holding is 20.15 times less risky than Excelsior Biopharma. It trades about 0.47 of its potential returns per unit of risk. Excelsior Biopharma is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  3,000  in Excelsior Biopharma on October 26, 2024 and sell it today you would earn a total of  215.00  from holding Excelsior Biopharma or generate 7.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CTBC Financial Holding  vs.  Excelsior Biopharma

CTBC Financial Holding

Risk-Adjusted Performance

29 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in CTBC Financial Holding are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, CTBC Financial is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Excelsior Biopharma

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Excelsior Biopharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Excelsior Biopharma may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with CTBC Financial and Excelsior Biopharma

The main advantage of trading using opposite CTBC Financial and Excelsior Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTBC Financial position performs unexpectedly, Excelsior Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Excelsior Biopharma will offset losses from the drop in Excelsior Biopharma's long position.

The idea behind CTBC Financial Holding and Excelsior Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..